Kaye Scholer led the defense before the California Court of Appeal of a joint motion for summary judgment we obtained last year in the Superior Court of California, Alameda County, on behalf of 15 of the leading brand name prescription drug manufacturers and PhRMA, their trade association. Seventeen retail California pharmacies sued under California’s antitrust law claiming that the defendants conspired in violation of the Cartwright Act, California’s antitrust law, to use Canadian drug prices as a floor for setting US prices for prescription drugs, and colluded to prevent re-importation of less expensive drugs from Canada to protect the object of the conspiracy.
The Kaye Scholer team consisted of Saul P. Morgenstern (argued summary judgment in the trial court), Aton Arbisser (argued in the Court of Appeal), Bryant Delgadillo (LA counsel), Karin E. Garvey (NY counsel), Amanda Myers (LA Associate), and Michael Schenk (LA paralegal).
Also of Interest
- GIR 100 Names Kaye Scholer a World Leader in Cross-Border Investigations October 10, 2016 • Recognitions
- Antitrust Jurisprudence in the Second Circuit October 1, 2016 • Articles
- NLJ Names Shores as Antitrust Trailblazer September 27, 2016 • Recognitions
- Morgenstern, Patterson Assess Second Circuit’s Antitrust Legacy in Fordham Law Review September 19, 2016 • Articles
- Arbisser Featured in The Recorder and Law360... September 7, 2016 • Media Mentions
- Consumer Products: Adapting to Innovation Fall 2016 • Reports / Newsletters
- ILS and Zinsser Analytic Shareholders Sell to Gardner Denver Medical September 2, 2016 • Client Successes
- Kaye Scholer Advises Veracen on Merger of Equals with Turner Investments August 31, 2016 • Client Successes
- Doing Deals with Competitors: Beware of Taking Minority Equity Stakes or Board Seats August 24, 2016 • Articles